Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU parliament could kill global anti-counterfeit agreement by summer

This article was originally published in Scrip

Executive Summary

The controversial Anti-Counterfeiting Trade Agreement, ACTA, aimed at tackling intellectual property rights violations across all sectors, could be dead in the water by the summer if the European Parliament follows the recommendations of its ACTA rapporteur, David Martin. Mr Martin will recommend that the parliament rejects the agreement, which would mean it could not be ratified in the EU. This could, in turn, influence whether countries outside the EU ratify it, say commentators.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC017030

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel